10 October 2018 - Karyn Robson and her family are paying $6,000 for her medication but time and funds are running out.
Imagine knowing that your life could be prolonged by a wonder drug that you simply can't afford.
It's PHARMAC's job to fund those drugs for New Zealanders - they have almost a billion dollars to spend each year to do so.
Over $200 million of that goes to cancer medicines, with around $50 million spent on Herceptin for breast cancer and Keytruda for melanoma.